Journal profile · HEMATOLOGY

Clinical Medicine Insights-Blood Disorders

ISSN 1179-545X · SAGE Publishing · United Kingdom

Clinical Medicine Insights-Blood Disorders: diamond open access (no APC); no APC; review about 8 weeks (community reports); 0 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ2Hematology · rank 55/123 · 55th percentile
Review timeabout 8 weeksCommunity average
APCNo APCDiamond open access (no APC)
Acceptance—No reports yet
Articles per year02025 · OpenAlex count

Scope

Aims, scope and focus

Clinical Medicine Insights-Blood Disorders is published by SAGE Publishing. By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Platelet Disorders and Treatments and Viral-associated cancers and disorders, together about 30.7% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)

Blood & Plasma is a peer-reviewed, gold open-access journal for research on blood and plasma that advances understanding of human physiology and disease, improves diagnosis and monitoring, and informs clinically relevant therapeutic approaches. The journal spans hematology, immunology, oncology, laboratory medicine and plasma science. View full journal description

From the journal's Aims & Scope

Research area (LetPub): HEMATOLOGY

Editorial board by country: none in mainland China; most named United States 11, Spain 4, Italy 3, India 2, United Kingdom 1 (26 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Lymphoma Diagnosis and TreatmentMedicine12.9%
  2. Platelet Disorders and TreatmentsMedicine9.9%
  3. Viral-associated cancers and disordersMedicine7.9%
  4. Blood transfusion and managementMedicine5.9%
  5. CNS Lymphoma Diagnosis and TreatmentMedicine5.9%
  6. Hematological disorders and diagnosticsMedicine5.9%
  7. Acute Myeloid Leukemia ResearchMedicine5%
  8. Blood Coagulation and Thrombosis MechanismsMedicine5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
HematologyQ255/12355th

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
3.7LetPub ·
SJR 2026-06
0.41LetPub ·
SNIP 2026-06
1.71LetPub ·
h-index
15OpenAlex ·
i10-index
22OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
100%LetPub ·

Articles by year OpenAlex count · 48 in total · the current year is incomplete

YearArticlesOpen accessCitations
20260063
20250079
202400110
202300112
202200137
202144130

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 8 weeksLetPub ·
Submission to publication (journal-reported)
about 8 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY, CC BY-NC
OpenAlexUSD 2,021——
LetPubNo APCNo—
Publisher websiteUSD 1,600——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted9
  1. case reportOpen Access Case report First published Jan 3, 2024 Management of a Young Patient With High-risk Multiple Myeloma Complicated by Acquired von Willebrand Syndrom…Length not stated
  2. editorialOpen Access Editorial First published Jan 20, 2026 Blood & Plasma: Advancing Interdisciplinary Research and Clinical PracticeLength not stated
  3. letterOpen Access Letter First published May 20, 2024 Revolutionizing Sickle Cell Disease Treatment: Unveiling CRISPR and Lentiviral Therapies—Navigating Complexities…Length not stated
  4. original research articleView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
  5. perspectiveView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
  6. research articleView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
  7. reviewView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
  8. review articleView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
  9. systematic reviewView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
Authorship Author contributions

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

Source ↗Publisher website ·
Data availability Data availability

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

Source ↗Publisher website ·
Publication ethics Ethical considerations

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. You can find information on what to say in your ethical statements as well as example statements on our Publication ethics and research integrity policies page. All papers r…

Source ↗Publisher website ·
Open access Publishing fees and open access

Blood & Plasma is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder, in…

Source ↗Publisher website ·
Peer review Peer review policy

The following summary describes the peer review process for this journal: Identity transparency: Single Anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

Source ↗Publisher website ·
Plagiarism Plagiarism

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

Source ↗Publisher website ·
Preprints Preprints

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

Source ↗Publisher website ·
Trial registration / reporting guidelines Clinical trial registration

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
SAGE Publishing
Country or region
United Kingdom
Language
English
ISSN
1179-545X
Official links

FAQ

Frequently asked questions about Clinical Medicine Insights-Blood Disorders

How long does peer review take at Clinical Medicine Insights-Blood Disorders?

Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Clinical Medicine Insights-Blood Disorders based?

Of the 26 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (11), Spain (4) and Italy (3). Counted from the institutions listed on the board page; for reference only.

Which databases index Clinical Medicine Insights-Blood Disorders?

According to LetPub and DOAJ records, Clinical Medicine Insights-Blood Disorders is indexed in Scopus and DOAJ.

Is Clinical Medicine Insights-Blood Disorders open access, and what is the APC?

Clinical Medicine Insights-Blood Disorders is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .